Physician

Alexander Williams, M.D.

According to 2025 Medicare claims, Alexander Williams, M.D. (NPI: 1073977310) practices endocrinology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is BAYCARE MEDICAL GROUP, INC. (NPI: 1043269871; TIN: 593140335) and primary practice location at 33756-3800. Williams is affiliated with the Pearl Network, LLC (ACO ID: D0243), participating under the REACH model.

Williams' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 285 traditional Medicare patients, billed 1,095 HCPCS/CPT codes, and received $61,875 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,705 prescription claims across 504 beneficiaries totaling $1,405,703 in drug costs, led by Ozempic (Semaglutide). DME data shows 306 claims. Open Payments data shows 148 records totaling $7,220. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,974 to $1,405,703. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	84	104	$10,740
2022	430	903	$74,935
2023	470	850	$56,971
2024	285	1,095	$61,875

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	59	118	$4,974
2018	36	202	$5,001
2019	16	38	$4,284
2020	20	37	$7,716
2021	64	159	$67,361
2022	404	2,045	$1,316,667
2023	617	3,689	$2,496,077
2024	504	2,705	$1,405,703

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	133	374	$59,305
2023	209	933	$161,688
2024	131	306	$110,729

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	94	94	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	183	324	$94
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	55	104	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	192	316	$12
83036	Hemoglobin a1c level	76	92	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	179	8,046	$256,549
Mounjaro	Tirzepatide	164	6,522	$237,208
Jardiance	Empagliflozin	143	9,416	$182,096
Rybelsus	Semaglutide	38	2,460	$77,189
Farxiga	Dapagliflozin Propanediol	60	3,911	$72,857

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	65	205	$101,572
E0784	External ambulatory infusion pump, insulin	Y	N/R	14	$4,650
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	16	16	$3,596
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	33	45	$875
A4259	Lancets, per box of 100	N	17	26	$34

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	148	$7,220	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander Williams, M.D.?

Tedicare shows public-source Medicare data for Alexander Williams, M.D. (NPI 1073977310), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Williams, M.D. have ACO affiliation data?

Alexander Williams, M.D. is shown with ACO affiliation data for Pearl Network, LLC (REACH, ACO ID D0243).

What billing organization is linked to Alexander Williams, M.D.?

Alexander Williams, M.D. is linked to BAYCARE MEDICAL GROUP, INC. (billing NPI 1043269871) in the available physician profile data.

Does Alexander Williams, M.D. have Open Payments data?

Alexander Williams, M.D. has 148 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.